|Country||United States - SIR Ranking of United States||
|Subject Area and Category||Immunology and Microbiology|
Immunology and Allergy
Pharmacology, Toxicology and Pharmaceutics
|Publisher||SAGE Publications Inc.|
|Scope||Therapeutic Advances in Vaccines and Immunotherapy delivers the highest quality peer-reviewed open access articles, reviews, and scholarly comment relating to advances in the fields of vaccinology and immunotherapy. It is now recognised that the immune response can be manipulated in a plethora of different ways that can ultimately deliver therapeutic output for infectious disease, chronic disease and cancer in patients. As such, there has been a recent explosion of research activity investigating different immunotherapeutic strategies, which has been driven in part by the successful impact of checkpoint inhibitors in hitherto treatment-resistant cancers such as melanomas. The journal covers all research relevant to the prospects of recovering a natural, or enhancing an induced, immune response, reporting on advances in vaccination (both prophylactic and therapeutic) as well as an ever-growing repertoire of other immunotherapeutic interventions. The editors welcome original articles across all areas of immunotherapy. The journal publishes original research articles and review articles primarily. Original research manuscripts may include laboratory, animal or human/clinical studies - all phases. Letters to the Editor and Case Reports will also be considered.|
|Join the conversation about this journal|
The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.
|Immunology and Allergy||2015||Q2|
|Immunology and Allergy||2016||Q1|
|Immunology and Allergy||2017||Q1|
The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.
This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.
|Cites per document||Year||Value|
|Cites / Doc. (4 years)||2015||6.000|
|Cites / Doc. (4 years)||2016||10.333|
|Cites / Doc. (4 years)||2017||10.333|
|Cites / Doc. (3 years)||2015||6.000|
|Cites / Doc. (3 years)||2016||10.333|
|Cites / Doc. (3 years)||2017||10.333|
|Cites / Doc. (2 years)||2015||6.000|
|Cites / Doc. (2 years)||2016||10.333|
|Cites / Doc. (2 years)||2017||0.000|
Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.
Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.
|External Cites per document||2015||6.000|
|External Cites per document||2016||10.333|
|External Cites per document||2017||10.333|
|Cites per document||2015||6.000|
|Cites per document||2016||10.333|
|Cites per document||2017||10.333|
International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.
Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.
Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.